Official UK procurement notice
Anti-Infective Drugs 3 · UK public procurement notice
Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)
What is being bought
Published requirement descriptionGeneric Anti-Infective Drugs
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (4)
- Price: 30
- VFM: 20
- Price stability: 6
- Minimum order: 4
Published award criteria (5)
- Quality: Pass/Fail
- Price: 30
- VFM: 20
- Price stability: 6
- Minimum order: 4
- Price carries 60 of 60 points: a 10% discount moves about 6 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 23 Feb 2021, 22:56 GMT
- Last source update
- 23 Feb 2021, 22:56 GMT
- Authority reference
PAD-OJEU-45645- FTS notice number
2021/S 000-003638- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02959eFind a Tender
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK LTDGeneric Drugs Anti-Infective Drugs 3 | £24,835 † | — | Awarded |
| Selective Supplies LtdGeneric Drugs Anti-Infective Drugs 3 | £50,476 † | — | Awarded |
| Syri Limited (T/A Thame Laboratories)Generic Drugs Anti-Infective Drugs 3 | £1,766 † | — | Awarded |
| Teva UK LtdGeneric Drugs Anti-Infective Drugs 3 | £107,858 † | — | Awarded |
| Torrent PharmaceuticalsGeneric Drugs Anti-Infective Drugs 3 | £4,276 † | — | Awarded |
| Wockhardt UK LimitedGeneric Drugs Anti-Infective Drugs 3 | £13,383 † | — | Awarded |
| Zentiva Pharma UK LtdGeneric Drugs Anti-Infective Drugs 3 | £48,233 † | — | Awarded |
| Bowmed Ibisqus LimitedGeneric Drugs Anti-Infective Drugs 3 | £147,516 † | — | Awarded |
| Consilient Health LtdGeneric Drugs Anti-Infective Drugs 3 | £102,847 † | — | Awarded |
| Glaxo SmithklineGeneric Drugs Anti-Infective Drugs 3 | £4,358 † | — | Awarded |
5 further award records carry no date or value.
Contracts
Generic Drugs Anti-Infective Drugs 3 · ACCORD-UK LTD
- Signed
- 1 Feb 2021
- Value
- £24,835
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Selective Supplies Ltd
- Signed
- 1 Feb 2021
- Value
- £50,476
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Syri Limited (T/A Thame Laboratories)
- Signed
- 1 Feb 2021
- Value
- £1,766
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Teva UK Ltd
- Signed
- 1 Feb 2021
- Value
- £107,858
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Torrent Pharmaceuticals
- Signed
- 1 Feb 2021
- Value
- £4,276
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Wockhardt UK Limited
- Signed
- 1 Feb 2021
- Value
- £13,383
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Zentiva Pharma UK Ltd
- Signed
- 1 Feb 2021
- Value
- £48,233
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Bowmed Ibisqus Limited
- Signed
- 1 Feb 2021
- Value
- £147,516
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Consilient Health Ltd
- Signed
- 1 Feb 2021
- Value
- £102,847
- Status
- active
Generic Drugs Anti-Infective Drugs 3 · Glaxo Smithkline
- Signed
- 1 Feb 2021
- Value
- £4,358
- Status
- active
Generic Drugs Anti-Infective Drugs 3
- Signed
- 1 Feb 2021
- Value
- £51,795
- Status
- active
Generic Drugs Anti-Infective Drugs 3
- Signed
- 1 Feb 2021
- Value
- £20,022
- Status
- active
Generic Drugs Anti-Infective Drugs 3
- Signed
- 1 Feb 2021
- Value
- £2,079
- Status
- active
Generic Drugs Anti-Infective Drugs 3
- Signed
- 1 Feb 2021
- Value
- £73,709
- Status
- active
Generic Drugs Anti-Inective Drugs 3
- Signed
- 1 Feb 2021
- Value
- £123,145
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 24bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
Bidders & participating suppliers
15 commercial parties on the notice- Accord-UK LtdAwarded supplier
- Bowmed Ibisqus LtdAwarded supplier
- Consilient Health LtdAwarded supplier
- Glaxo SmithklineAwarded supplier
- Kent PharmaceuticalsAwarded supplier
- Morningside Pharmaceuticals LimitedAwarded supplier
- Neon Healthcare LtdAwarded supplier
- Pfizer LimitedAwarded supplier
- SanofiAwarded supplier
- Selective SuppliesAwarded supplier
Show 5 more suppliers
- Syri Limited T/A Thame LaboratoriesAwarded supplier
- Teva UK LtdAwarded supplier
- Torrent PharmaceuticalsAwarded supplier
- Wockhardt UK LimitedAwarded supplier
- Zentiva Pharma UK LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.